G Medical Innovations Holdings Ltd · OTC:GMVDF
G Medical Innovations — IPO Roadshow (March 2021)
23 slides from G Medical Innovations's IPO roadshow presentation, Mar 22, 2021
Slide 1: Our Mobile Devices and Data Monitoring Reduce Healthcare Costs
Our Mobile Devices and Data Monitoring Reduce Healthcare Costs and Improve Quantity of Care MEDICAL MARCH 2021 INVESTOR PRESENTATION Issuer Free Writing Prospectus Dated March 22, 2021 Filed Pursuant to Rule 433 Relating To Preliminary Prospectus Dated March 22 , 2021 Registration Statement No. 333
Slide 2: Forward-Looking Statements
This document contains forward - looking statements . In addition, from time to time, we or our representatives may make forward - looking statements orally or in writing . We base these forward - looking statements on our expectations and projections about future events, which we derive from the in
Slide 3: Free Writing Prospectus
G Medical Innovations 3 This presentation highlights basic information about us and the proposed offering . Because it is a summary, it does not contain all the information that you should consider before investing . We have filed a registration statement (including a preliminary prospectus) with th
Slide 4: The Offering
THE OFFERING G Medical Innovations 4 ISSUER G MEDICAL Proposed Maximum Aggregate Offering $18.0 M Price Range $5.00 - $7.00 Proposed Symbol GMVD Shares Offered 3,000,000 Over - Allotment Option 15% Pre - IPO Ordinary Shares Outstanding 10,414,684 Post - IPO Common Shares Outstanding 13,414,684 Use o
Slide 5: Investment Highlights
INVESTMENT HIGHLIGHTS G Medical Innovations 5 ▪ Founded in 2014, launched revenue - generating products and services in 2018 ▪ Led by individuals with more than 30 years of combined experience developing mobile embedded medical sensors and over 48 medical devices approved by the FDA ▪ Growth has bee
Slide 6: Diagnostic Data Is Essential for Care
▪ Medical professionals require diagnostic data to evaluate patients before, during and after healthcare engagements – a standard data set is collected by devices at every healthcare interaction ▪ In 2019, there were ~147 M hospital visits and ~884 M doctor visits in the US (CDC Website, 2021), at e
Slide 7: Mobile Devices + Remote Monitoring Devices Share Data Between Patients and Providers
MOBILE DEVICES + REMOTE MONITORING DEVICES SHARE DATA BETWEEN PATIENTS AND PROVIDERS MONITORING IMPROVES QUALITY OF CARE G Medical Innovations 7 Patented Technologies Scalable Manufacturing FDA – Approved Dedicated Sales Reps Professional and OTC Use Comprehensive Tests Medicare - Certified IDTF Onl
Slide 8: Continuous Recording and Monitoring: Cardiac Data and Telemetry
▪ Two models continuously monitor cardiac results up to 14 or 30 days with an ‘extended Holter - type’ device for use in hospital or at home ▪ Records up to 6 EKG leads on SD card or self - transmits ▪ Auto - Detect and Auto Transmission capabilities ▪ Third - party device connectivity ▪ 24/7 clinic
Slide 9: On Demand Data and Monitoring, Remote, User-Controlled
▪ US FDA - approved device produces diagnostic data with Electronic Medical Records ( EMR ) functionality ▪ Doctor - prescribed device and services tests, collects, stores, transmits and displays patient results accessed online or on Apple or Android app ▪ Remote, user - controlled as a stand - alon
Slide 10: Over-the-Counter Diagnostic Data Device and Monitoring
▪ FDA - approved and over - the - counter use by consumers to collect and store their own health diagnostic data ▪ Health - conscious individuals take an active role in their preventive health ▪ User - generated data retained in personal profiles in - app and online ▪ Subscription - based clinical m
Slide 11: Monitoring of Diagnostic Data
Medicare - Certified, Independent Diagnostic Testing Facilities ( IDTF ) ▪ Two wholly – owned HIPAA compliant US patient monitoring call centers ▪ Monitoring service model generates recurring revenue ▪ Irregular data flagged for proactive clinical or medical engagement ▪ Online, mobile app and call
Slide 12: Approved by 150+ Healthcare Insurers
APPROVED BY 150+ HEALTHCARE INSURERS G Medical Innovations 12 SOURCE: Selected Customers from G Medical Customer List, 2021 USED BY 150+ DOCTORS, HOSPITALS AND CLINICS SOURCE: Selected Customers from G Medical Customer List, 2021 66% of Healthcare insurance companies currently pay for remote data co
Slide 13: Growth Model and Competitor Matrix
# of Devices Needed Remote Operation Data Sets Collected Data Collection by User – Remote Monitoring G Medical 1 Many Others Many One FDA Approved Remote Operation Add New Functions OTC, Diagnostics and Monitoring G Medical Activity Trackers GROWTH MODEL G Medical Innovations 13 # of EKG Leads Conne
Slide 14: Management Team
MANAGEMENT TEAM Dr . Yacov Geva Managing Director and CEO , Executive Director A well - known pioneer in the industry of Medical Devices and remote monitoring services, and co - founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd . ) . Successfully led LifeWatch to a
Slide 15: Board of Directors
BOARD OF DIRECTORS Dr . Kenneth R . Melani Non - Executive Chairman, began his career in 1981 as a practicing physician growing his internal medicine practice into the largest multi - specialty physician practice in Western Pennsylvania . In the mid 1980 ’s he helped start a physician hospital organ
Slide 16: Use of Proceeds and Recent Events
USE OF PROCEEDS G Medical Innovations 16 ▪ 17 University Hospitals (UH) Approves G Medical Devices and Monitoring for In - Patient and Out - Patient Care ▪ Guthy - Renker Engaged for PRIZMA G2 Marketing and Social Media Outreach Beginning Q2 2021 ▪ G Medical Launches New, PRIZMA G2 Online Sales Plat
Slide 17: Comps
G Medical Innovations 17 COMPS COMPANY TICKER BUSINESS DESCRIPTION 2020 REVENUES (as reported in SEC filings) MARKET CAP (as reported by CapitalIQ on March 17, 2021) PRICE/ SALES RATIO (1) Teledoc Health NASDAQ : TDOC Virtual healthcare services $1,094 M $29,028 M 26.5x iRythum NASDAQ: IRTC Develops
Slide 18: Contact Us
Mobility in Healthcare © 2021 G Medical Innovations, Inc. All rights reserved. MEDICAL CONTACT US G Medical Innovations Ltd USA 12708 Riata Vista Circle Suite A - 103 Austin, TX 78727 USA Dr. Yacov Geva, CEO yacovg@gmedinnovations.com
Slide 19: Appendix
APPENDIX G Medical Innovations 19
Slide 20: Customer Segments: U.S. Healthcare Providers and Patients
Devices are delivered to Jeff at home or hospital - administered For preventative, outpatient or in patient care Jeff’s doctor prescribes a G Medical device Continuous or On - demand diagnostic data transmitted to the cloud/web Clinical Monitoring for at - home at home patients and triage with a phy
Slide 21: Customer Segments: Individual U.S. OTC Consumers
Regularly Collected Health Data stored in the individual's cloud Healthy - Minded Individuals want to take a more proactive role in their health Monitoring Service Subscription engages a clinician to review and interpret data plus An Option To Schedule a telehealth Evaluation By a Doctor PRIZMA G2 U
Slide 22: Patent Status
PATENT STATUS G Medical Innovations 22
Slide 23: Web Portal for Patients and Physicians
WEB PORTAL FOR PATIENTS AND PHYSICIANS G Medical Innovations 23 Top Menu help and 3rd party systems like CRM, Call Center and Online Store Patients medical history with option to edit and view for comprehensive status Abnormal measurements indication based on flexible time filter Incoming calls and
G Medical Innovations Holdings — IPO Roadshow (March 2021) on 6ix